menstrual blood stem cells

Cell therapyexperimental

Clinical trial activity

3 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
3
Phase 3
1
Phase 4
0

Earliest trial started Mar 1, 2014 (NCT02095444)

Timeline

2010s

  1. Jan 1, 2014

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2020

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

  • Stem CellSupplementation

    Stem Cell supplementation

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • menstrual blood stem cells

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05019287Phase 1/Phase 2 (Phase 2)Apr 17, 2021Avicenna Medical Center, Tehran University of Medical Science, University of Tehran
NCT05703308Phase 3Jun 21, 2020Avicenna Medical Center
NCT02095444Phase 1/Phase 2 (Phase 2)Mar 1, 2014S-Evans Biosciences Co.,Ltd., Zhejiang University
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Avicenna Medical CenterAcademic/Hospital2222020
S-Evans Biosciences Co.,Ltd.For profit1112014
Tehran University of Medical ScienceAcademic/Hospital1012021
University of TehranAcademic/Hospital1012021
Zhejiang UniversityAcademic/Hospital1012014
5 organizations
Page 1 / 1